Market Updates

KitoZyme Finalizes Capital Increase of €9 Million

Belgium- based KitoZyme, an innovative company active in the biochemistry sector and a leader in its market segment, has announced the recent finalization of a capital increase for a total amount of 9 million euros. The issue of new shares was reserved for and entirely underwritten by the company’s two main shareholders: the company Valois (Mestdagh Group and Montulet family) and the SRIW, the Wallonia Regional Investment Company. This capital increase will significantly build the company’s equity and will allow it to actively continue developing new products and its international commercial expansion.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters